Patents by Inventor Susan LIU-CHEN

Susan LIU-CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT INHIBITORS FOR TREATING DRUG-INDUCED COMPLEMENT-MEDIATED RESPONSE
    Publication number: 20220356234
    Abstract: Disclosed herein are methods and compositions for reducing or eliminating a complement-mediated response in a patient receiving treatment for a disease or disorder wherein one or more therapeutic agents is administered to the patient along with one or more complement inhibitors. Administration of the complement inhibitor along with the therapeutic agent results in a reduced or eliminated complement-mediated response, such as a reduction or elimination of symptoms associated with Complement Activation-Related Pseudoallergy (CARPA) or Cytokine Release Syndrome (CRS).
    Type: Application
    Filed: October 1, 2020
    Publication date: November 10, 2022
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Yi Wang, Susan Liu-Chen
  • Treating seizure with recombinant alkaline phosphatase
    Patent number: 11224638
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: January 18, 2022
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Andre Marozsan, Denise Devore, Susan Liu-Chen
  • TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE
    Publication number: 20200093898
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Application
    Filed: October 18, 2019
    Publication date: March 26, 2020
    Inventors: Andre MAROZSAN, Denise DEVORE, Susan LIU-CHEN
  • Treating seizure with recombinant alkaline phosphatase
    Patent number: 10449236
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: October 22, 2019
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Andre Marozsan, Denise Devore, Susan Liu-Chen
  • TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE
    Publication number: 20170360899
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Inventors: Andre MAROZSAN, Denise DEVORE, Susan LIU-CHEN